428 related articles for article (PubMed ID: 19651173)
1. Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.
Cong Y; Yu JJ; Guentzel MN; Berton MT; Seshu J; Klose KE; Arulanandam BP
Vaccine; 2009 Sep; 27(41):5554-61. PubMed ID: 19651173
[TBL] [Abstract][Full Text] [Related]
2. Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.
Ray HJ; Cong Y; Murthy AK; Selby DM; Klose KE; Barker JR; Guentzel MN; Arulanandam BP
Clin Vaccine Immunol; 2009 Apr; 16(4):444-52. PubMed ID: 19211773
[TBL] [Abstract][Full Text] [Related]
3. Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain.
Sanapala S; Yu JJ; Murthy AK; Li W; Guentzel MN; Chambers JP; Klose KE; Arulanandam BP
Infect Immun; 2012 Jun; 80(6):2177-85. PubMed ID: 22493083
[TBL] [Abstract][Full Text] [Related]
4. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
[TBL] [Abstract][Full Text] [Related]
5. Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.
Pammit MA; Raulie EK; Lauriano CM; Klose KE; Arulanandam BP
Infect Immun; 2006 Apr; 74(4):2063-71. PubMed ID: 16552035
[TBL] [Abstract][Full Text] [Related]
6. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.
Conlan JW; Shen H; Golovliov I; Zingmark C; Oyston PC; Chen W; House RV; Sjöstedt A
Vaccine; 2010 Feb; 28(7):1824-31. PubMed ID: 20018266
[TBL] [Abstract][Full Text] [Related]
7. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
Jia Q; Horwitz MA
Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
[No Abstract] [Full Text] [Related]
8. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.
Golovliov I; Twine SM; Shen H; Sjostedt A; Conlan W
PLoS One; 2013; 8(11):e78671. PubMed ID: 24236032
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Schu S4
Cunningham AL; Mann BJ; Qin A; Santiago AE; Grassel C; Lipsky M; Vogel SN; Barry EM
Virulence; 2020 Dec; 11(1):283-294. PubMed ID: 32241221
[TBL] [Abstract][Full Text] [Related]
10. Inhalation of Francisella novicida Delta mglA causes replicative infection that elicits innate and adaptive responses but is not protective against invasive pneumonic tularemia.
West TE; Pelletier MR; Majure MC; Lembo A; Hajjar AM; Skerrett SJ
Microbes Infect; 2008 Jun; 10(7):773-80. PubMed ID: 18539500
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates.
Santiago AE; Mann BJ; Qin A; Cunningham AL; Cole LE; Grassel C; Vogel SN; Levine MM; Barry EM
Pathog Dis; 2015 Aug; 73(6):ftv036. PubMed ID: 25986219
[TBL] [Abstract][Full Text] [Related]
12. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
Twine S; Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W
Vaccine; 2012 May; 30(24):3634-45. PubMed ID: 22484348
[TBL] [Abstract][Full Text] [Related]
13. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
[TBL] [Abstract][Full Text] [Related]
14. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice.
Quarry JE; Isherwood KE; Michell SL; Diaper H; Titball RW; Oyston PC
Vaccine; 2007 Mar; 25(11):2011-8. PubMed ID: 17241711
[TBL] [Abstract][Full Text] [Related]
15. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).
De Pascalis R; Chou AY; Ryden P; Kennett NJ; Sjöstedt A; Elkins KL
mBio; 2014 Apr; 5(2):e00936. PubMed ID: 24713322
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immunization with live attenuated Francisella novicida U112ΔiglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat model.
Signarovitz AL; Ray HJ; Yu JJ; Guentzel MN; Chambers JP; Klose KE; Arulanandam BP
PLoS One; 2012; 7(10):e47639. PubMed ID: 23118885
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T cells are required during priming but not the effector phase of antibody-mediated IFN-gamma-dependent protective immunity against pulmonary Francisella novicida infection.
Powell HJ; Cong Y; Yu JJ; Guentzel MN; Berton MT; Klose KE; Murthy AK; Arulanandam BP
Immunol Cell Biol; 2008; 86(6):515-22. PubMed ID: 18427567
[TBL] [Abstract][Full Text] [Related]
18. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
[No Abstract] [Full Text] [Related]
19. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
KuoLee R; Harris G; Conlan JW; Chen W
Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
[TBL] [Abstract][Full Text] [Related]
20. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J
Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
